Advertisement
Persons > All
Please find below persons from Ireland & the United Kingdom (GB) or related to organisations from these countries.Total search results: 4888 | Ordered by Person (descending)
1 2 3 ... 47 48 49
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Ørum, Henrik (Santaris Pharma 200712 CSO + VP BusDev) | Business Development Manager / Strategy Manager | Roche (Group) | Denmark_o |
Ørnskov, Flemming (Shire 201301– CEO before Bayer Chief Marketing Officer + Bausch & Lomb + Ikaria + Novartis) | Chief Executive Officer (CEO) | Takeda (Group) | Ireland (cl4) |
Štrancar, Aleš (BIA Separations 201309 CEO + Chief Business Development Officer) | Chief Executive Officer (CEO) | Sartorius (Group) | Slovenia_o |
Özbal, Can (PureHoney Technologies 2014– CEO + Co-Founder before BIOCIUS + BioTrove) | Chief Operating Officer (COO) | PureHoney Technologies (US) | Massachusetts (federal state) |
Zörgiebel, Wilhelm (Willi) (Biotype Diagnostic 201107 Managing Director + Owner before Priontype) | Managing Director | Qiagen (Group) | Sachsen (federal state) |
Zweifach, Sanford S. (Sandy) (Pathway Diagnostics 200503 CEO) | Chief Executive Officer (CEO) | Pathway Diagnostics Corporation | California (federal state) |
Zwanziger, Ron (Alere/Inverness Medical 200603–201406 CEO RESIGNED 7/14) | Chief Executive Officer (CEO) | Abbott (Group) | Massachusetts (federal state) |
Zou, Johnny (Primavera Capital 202109 at Primavera Venture Partners) | Investment Manager | Primavera Capital (Group) | China_o |
Zook, Tony (AstraZeneca –201301 EVP Global Commercial LEFT 1/13 before CEO of AstraZeneca USA) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | East of England (region) |
Zohar, Daphne (PureTech Health 2016 CEO + Co-Founder) | Chief Executive Officer (CEO) | PureTech Health (Group) | Greater London (region) |
Zisman, Einat (FutuRx 201705 CEO + Hadassah 201309 CEO of Hadasit) | Chief Executive Officer (CEO) | Hadassah (HMO) (Group) | Israel_o |
Zipkin, Mark (IB Communicsion 202212) | Public Relations Manager / Investor Relations Manager | Image Box Ltd. (Image Box PR / IB Communications) | South East England (region) |
Zins, Antoine (Eurazeo 202004 Investment Manager at Idinvest Partners) | Investment Manager | Eurazeo (Group) | Île-de-France (region) |
Zink, Barbara (Basilea 201109 Head Corporate Development) | Business Development Manager / Strategy Manager | Basilea (Group) | Northwestern Switzerland (region) |
Ziltzer, Andrea (Consilium Strategic Communications 201909– Senior Advisor at CSC US Inc) | Public Relations Manager / Investor Relations Manager | ICR (Group) | New York (federal state) |
Ziegenfuss, Christopher D. (Chris) (BioPharmaSpec 201803– VP US Operations BioPharmaSpec Inc) | Regional manager | BioPharmaSpec (Group) | Pennsylvania (federal state) |
Zhu, Jackson (My-BioMed Biotechnology Co Ltd 201704 CEO) | Chief Executive Officer (CEO) | Ningbo My-BioMed Biotechnology Co., Ltd. (MBM) | Zhejiang (Chekiang) (province) |
Zhou, Tingting (Novogene 202312 VP of Novogene Europe) | President/Director/Head Business Group/Unit/Division | Novogene (Group) | United Kingdom (state/region unspecified) |
Zhou, Jingye (Eccogene 202311 CEO + Co-Founder before Lilly + GSK + Tetraphase Pharmaceutical) | Chief Executive Officer (CEO) | Eccogene (CN) | Shanghai (province) |
Zhou, Jason (China Resources Group 202008 CEO + Managing Director of CR-CP Life Science Fund) | Chief Executive Officer (CEO) | China Resources Group (Group) | China_o |
Zheng, Ran (Landmark Bio 202107– CEO before Orchard Therapeutics + Amgen + Diosynth + Genzyme) | Chief Technology/Technical Officer (CTO) | Landmark Bio PBLLC | Massachusetts (federal state) |
Zhang, Yehong (Luye Pharma 201805 Head of Luye Pharma International) | President/Director/Head Business Group/Unit/Division | Luye Pharma Group Ltd. (02186.HK) | Shanghai (province) |
Zhang, Patrick (Horizons Ventures 201803) | Investment Manager | Horizons Ventures (Li Ka-shing) | |
Zhang, Long (MindRank 202309 President of China + Co-Founder) | President/Director/Head Business Group/Unit/Division | MindRank (Group) | Shanghai (province) |
Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) | Chief Executive Officer (CEO) | Valneva (Group) | Wien (state) |
Zettl, Sophie (CEBINA 202003 before Arsanis + MedImmune/AZ) | Business Development Manager / Strategy Manager | CEBINA GmbH (Central European Biotech Incubator and Accelerator) | Wien (state) |
Zeskind, Ben (Immuneering 201806 CEO) | Chief Executive Officer (CEO) | Immuneering Corporation | Massachusetts (federal state) |
Zeise, Antje (Epigenomics 201112 Manager IR | PR) | Public Relations Manager / Investor Relations Manager | Epigenomics (Group) | Berlin (federal state) |
Zavitsanos, Paul (Agilent 201006 ww Food Program Manager) | n. a. | Agilent (Group) | California (federal state) |
Zapico, David A. (AMETEK 201608 CEO) | Chief Executive Officer (CEO) | AMETEK (Group) | Pennsylvania (federal state) |
Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head) | Chief Executive Officer (CEO) | GSK (Group) | Greater London (region) |
Zajicek, George (Axis-Shield –200512–200804– BusDev Director before Unipath Ltd + Boehringer Ingelheim) | Business Development Manager / Strategy Manager | Abbott (Group) | Scotland |
Zaccagnini, Kiki (Instinctif Partners 202007) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
Yver, Antoine (AstraZeneca 201309 VP + Head of Oncology in Global Medicines Development Unit) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | East of England (region) |
Yusibov, Vidadi (Fraunhofer USA 201009 Exec Director CMB + iBio 201009 CSO) | Researcher (university / research institute) | Fraunhofer (Group) | Delaware (federal state) |
Yuryev, Anton (Ariadne Genomics 200610 Director of Application Science) | n. a. | Reed Elsevier (Group) | Maryland (federal state) |
Yu, Ying Qing (Waters 201608 Senior Science Manager) | n. a. | Waters (Group) | Massachusetts (federal state) |
Yu, Guo-Liang (Epitomics 201105 CEO) | Chief Executive Officer (CEO) | Abcam (Group) | California (federal state) |
Yu, Frank (Ally Bridge Group 201702 CEO + CIO + Founder) | Chief Executive Officer (CEO) | Ally Bridge Group (ABG) | Hong Kong (province) |
Yousaf, Shaf (Sigma-Aldrich 201412 VP Tech + BusDev before Life Technologies + Applied Biosystems + Sigma-Aldrich) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | California (federal state) |
Young, Sharon (Strategic Scientific 200902 Director) | President/Director/Head Business Group/Unit/Division | Stratech Scientific Ltd. | East of England (region) |
Young, Paul (Waters 201201 Senior Director, Food + Environment Business Operations) | n. a. | Waters (Group) | Massachusetts (federal state) |
Young, Michael (Lindus Health 202308 Co-Founder) | Company Founder | Lindus Health Ltd. | Greater London (region) |
Young, Malcolm (e-Therapeutics 2007–201607 CEO founded e-Therapeutics 2003 STEPPED DOWN 7/16) | Chief Executive Officer (CEO) | e-Therapeutics plc (AIM: ETX) | South East England (region) |
Young, Joshua (Bruker 201301– VP Investor Relations before Merck KGA + Millipore LEFT BEFORE 7/16) | Public Relations Manager / Investor Relations Manager | Bruker (Group) | Massachusetts (federal state) |
Young, Alethia (Bicycle Therapeutics 202307– CFO before Graphite Bio + Cantor Fitzgerald + Credit Suisse + Dt Bank) | Chief Financial Officer (CFO) | Bicycle Therapeutics (Group) | East of England (region) |
Yost, Richard A. (Univ Florida 201406 Head of Analytical Chemistry) | Professor | University of Florida | Florida (federal state) |
York, Gwill (Lighthouse Capital Partners 202110 Founding Managing Director) | Managing Director | Lighthouse Capital Partners (US) | Massachusetts (federal state) |
Yoo, Stephen (Anjarium Biosciences 202206– CEO before Third Harmonic Bio + Regenxbio + MedImmune + Abbott Labs) | Chief Executive Officer (CEO) | Anjarium Biosciences AG | Zürich (region) |
Yokoyama, Chikafumi (ReproCell 201511 CEO) | Chief Executive Officer (CEO) | ReproCell (Group) | Kanto (region) |
Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) | Chief Executive Officer (CEO) | Pieris (Group) | Bayern (federal state) |
Yeo, Marcus (Definigen Ltd 201406 CEO) | Chief Executive Officer (CEO) | DefiniGen Ltd. | East of England (region) |
Yemm, Stephen (Steve) (Optibrium 202301– Chief Commercial Officer before Paradigm4 + Aigenpulse + BioData + Vialis) | Chief Commercial Officer (CCO) | Optibrium (Group) | East of England (region) |
Yelle, Michael (Mike) (Waters 201405 VP Consumable Business Unit) | President/Director/Head Business Group/Unit/Division | Waters (Group) | Massachusetts (federal state) |
Yedid, Bob (LifeSci 201806 LifeSci Advisors LLC) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | New York (federal state) |
Yeatman, Graham (Retroscreen Virology 201307 Financial Director) | Chief Financial Officer (CFO) | Retroscreen Virology (Group) | Greater London (region) |
Yeatman, Eric (Microsaic Systems 201307– Non-exeuctive Director before Chairman + acting CEO) | Board member, non-executive | Microsaic Systems plc (AIM: MSYS) | South East England (region) |
Yeadon, Mike (Ziarco Pharma 201211– CEO + founder before Pfizer Research UK) | Chief Executive Officer (CEO) | Novartis (Group) | South East England (region) |
Yates, Chris (Abingdon Health 201710 CEO) | Chief Executive Officer (CEO) | Abingdon Health (Group) | Yorkshire and the Humber (region) |
Yasukawa, Kenji (Astellas 201808 CEO) | Chief Executive Officer (CEO) | Astellas (Group) | Kanto (region) |
Yarkoni, Orr (Colorfix 202211 CEO Co-Founder) | Chief Executive Officer (CEO) | Colorifix Ltd. | East of England (region) |
Yao, Zhizhong (Joel) (Sofinnova 202312 Partner in Biovelocita initiative) | Partner (venture partner) | ||
Yao, Zhengbin (Bing) (ArriVent BioPharma 202401 CEO + Co-Founder before Viela Bio + MedImmune) | Chief Executive Officer (CEO) | Viela Bio Inc. | Maryland (federal state) |
Yao, Lina (Teon Therapeutics 202102 CEO + Founder) | Chief Executive Officer (CEO) | Teon Therapeutics (US) | California (federal state) |
Yamashita, Takeyoshi (Kyowa Kirin 202011 Executive Officer, Director Corporate Strategy + Planning) | Business Development Manager / Strategy Manager | Kyowa Kirin (Group) | Kanto (region) |
Yamanaka, Shinya (Univ Kyoto 201004– Director of CiRA + Nobel Laureate 2012) | Professor | University of Kyoto (Kyoto University) | Kinki (region) |
Yamada, Tadataka (Tachi) (Frazier 201902 Venture Partner at Frazier Healthcare before Takeda + Gates Foundation + GSK) | Partner (venture partner) | Frazier (Group) | California (federal state) |
Yakneen, Sergei (Alphabet 202205– CTO at Isomorphic Labs before Sophia Genetics + Amazon + BPS) | Chief Technology/Technical Officer (CTO) | Alphabet (formerly Google) (Group) | Greater London (region) |
Yakir, Shaike (Procognia Israel 200609 President) | n. a. | Procognia (Group) | Israel_o |
Yadi, Hakim A. (Closed Loop Medicine 202203 CEO + Co-Founder) | Chief Executive Officer (CEO) | Closed Loop Medicine Ltd. | East of England (region) |
Yachi, Toshiyuki (Biotage 201209 VP Marketing) | Sales Manager / Marketing Manager | Biotage (Group) | Uppsala (region) |
Xu, Joanne (SoftBank 202106 Partner at SoftBank Investment Advisers + 202106– Board Director at Exscientia) | Partner (venture partner) | SoftBank (Group) | |
Xu, Charles (Labcare Scientific 201004 Managing Director) | Managing Director | Labcare Scientific Group | Shanghai (province) |
Wylie, Paul (TTP LabTech 200801 Senior Commercial Scientist) | n. a. | SPT Labtech (Group) | East of England (region) |
Wykeman, Nick (Allergy Therapeutics 201709 Finance Director) | Chief Financial Officer (CFO) | Allergy Therapeutics (Group) | South East England (region) |
Wyatt, Mark (Swansea Univ 200208–200910– Research Officer EPSCR NMSSC) | Researcher (university / research institute) | Swansea University | Wales |
Wyatt, Geof (Wyatt Technology 201007 President) | President/Director/Head Business Group/Unit/Division | Waters (Group) | California (federal state) |
Wuurman, Bart (Apaxen 202011– CEO before Lyramid + Lanthio Pharma + AM-Pharma + De Novo Pharma + Antisoma) | Chief Executive Officer (CEO) | Apaxen S.A. | Wallonia (region) |
Wu, Dong (Covidien 201208 VP China R&D) | Research & Development Manager | Covidien (Group) | Shanghai (province) |
Wu, Dee (University of Oklahoma Health Sciences Center 200610 Associate Prof) | n. a. | University of Oklahoma | Oklahoma (federal state) |
Wu, Chengbin (EpimAb Biotherapeutics 201610 CEO + Founder) | Chief Executive Officer (CEO) | EpimAb Biotherapeutics (Group) | Shanghai (province) |
Wrighton-Smith, Peter (Oxford Immunotec 200508 CEO) | Chief Executive Officer (CEO) | Oxford Immunotec (Group) | South East England (region) |
Wright, Robin (MiNA Therapeutics 202101– CFO before Pharming + Karolinska Development + Orexo + Citibank) | Chief Financial Officer (CFO) | MiNA Therapeutics Ltd. | Greater London (region) |
Wright, Moray (Parkwalk Advisors 201803 CEO) | Chief Executive Officer (CEO) | IP Group (Group) | Greater London (region) |
Wright, Edward (Bayer 201611 Bayer Yakuhin) | n. a. | Bayer (Group) | Kinki (region) |
Wright, Doug (Aviva 201803 Medical Director at Aviva) | n. a. | Aviva (Group) [Insurance Group] | |
Wright, Chris (Molecular Vision 200705 Executive Chairman) | President/Director/Head Business Group/Unit/Division | Molecular Vision Ltd. | Greater London (region) |
Wray, Jonny (e-Therapeutics 201801 Head of Discovery Informatics) | n. a. | e-Therapeutics plc (AIM: ETX) | South East England (region) |
Wortelmann, Thomas (GAS GmbH 201311 Managing Director) | Managing Director | Imspex (Group) | Nordrhein-Westfalen (federal state) |
Worswick, Richard (LGC 200001) | n. a. | LGC (Group) | United Kingdom (state/region unspecified) |
Worland, Steve (Effector Therapeutics 201512 CEO before Anadys + Pfizer) | Chief Executive Officer (CEO) | Effector Therapeutics Inc. | California (federal state) |
Woolfson, Dek (Univ Bristol 201401 Prof School of Chemistry + Biochemistry + Director of BrisSynBio Centre) | Professor | University of Bristol, BrisSynBio Centre | South West England (region) |
Woolfson, Adrian (Replay 202208 Executive Chair + Co-Founder before Sangamo + Nouscom + Pfizer + BMS) | Board member, executive | Replay (Group) | California (federal state) |
Woolfenden, Elizabeth (Liz) (Markes 200902 Director) | President/Director/Head Business Group/Unit/Division | Schauenburg (Group) | Wales |
Woolf, Nick (Oxford Biomedica 200201– CBO before ABN AMRO) | Chief Business Officer (CBO) | Oxford Biomedica (Group) | South East England (region) |
Woodward, Alan (Simbec Research 201305 Business Development Manager) | Business Development Manager / Strategy Manager | Simbec Research Ltd. | Wales |
Woods, R. Keith (Argen-X 201804– COO before Alexion + Roche + Amgen + Eisai) | Chief Operating Officer (COO) | Argenx (Argen-X) (Group) | North Brabant (province, NL) |
Woods, Kate (Northbank 200411) | n. a. | Instinctif Partners (Group) | Bayern (federal state) |
Woodruff, Mark (Fortis Technologies 201405 Sales + Marketing Director) | Sales Manager / Marketing Manager | Fortis Technologies Ltd. | North West England (region) |
Woodrow, Gordon (Proteros Biostructures 201008 EVP Strategic Alliances) | Business Development Manager / Strategy Manager | Proteros (Group) | South East England (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top